MicroRNA-184 antagonizes microRNA-205 to maintain SHIP2 levels in epithelia

Despite their potential to regulate approximately one-third of the whole genome, relatively few microRNA (miRNA) targets have been experimentally validated, particularly in stratified squamous epithelia. Here we demonstrate not only that the lipid phosphatase SHIP2 is a target of miRNA-205 (miR-205) in epithelial cells, but, more importantly, that the corneal epithelial-specific miR-184 can interfere with the ability of miR-205 to suppress SHIP2 levels. This is the first example of a miRNA negatively regulating another to maintain levels of a target protein. Interfering with miR-205 function by using a synthetic antagomir, or by the ectopic expression of miR-184, leads to a coordinated damping of the Akt signaling pathway via SHIP2 induction. This was associated with a marked increase in keratinocyte apoptosis and cell death. Aggressive squamous cell carcinoma (SCC) cells exhibited elevated levels of miR-205. This was associated with a concomitant reduction in SHIP2 levels. Partial knockdown of endogenous miR-205 in SCCs markedly decreased phosphorylated Akt and phosphorylated BAD levels and increased apoptosis. We were able to increase SHIP2 levels in SCC cells after inhibition of miR-205. Therefore, miR-205 might have diagnostic value in determining the aggressivity of SCCs. Blockage of miR-205 activity with an antagomir or via ectopic expression of miR-184 could be novel therapeutic approaches for treating aggressive SCCs.

[1]  Chang-Zheng Chen,et al.  MicroRNAs as oncogenes and tumor suppressors. , 2005, The New England journal of medicine.

[2]  V. Ambros,et al.  Expression profiling of mammalian microRNAs uncovers a subset of brain-expressed microRNAs with possible roles in murine and human neuronal differentiation , 2004, Genome Biology.

[3]  Yong Zhao,et al.  Serum response factor regulates a muscle-specific microRNA that targets Hand2 during cardiogenesis , 2005, Nature.

[4]  H. Horvitz,et al.  MicroRNA expression profiles classify human cancers , 2005, Nature.

[5]  A. Roth,et al.  Clinical and pathologic description of 17 cases of corneal intraepithelial neoplasia. , 1984, American journal of ophthalmology.

[6]  R. Lavker,et al.  MicroRNAs of the mammalian eye display distinct and overlapping tissue specificity. , 2006, Molecular vision.

[7]  T. Golub,et al.  Impaired microRNA processing enhances cellular transformation and tumorigenesis , 2007, Nature Genetics.

[8]  C. Croce,et al.  MicroRNA gene expression deregulation in human breast cancer. , 2005, Cancer research.

[9]  Yuichi Makino,et al.  Inhibitory PAS domain protein is a negative regulator of hypoxia-inducible gene expression , 2001, Nature.

[10]  V. Ambros The functions of animal microRNAs , 2004, Nature.

[11]  Elaine Fuchs,et al.  A skin microRNA promotes differentiation by repressing ‘stemness’ , 2008, Nature.

[12]  G. Hannon,et al.  The miRNA-Processing Enzyme Dicer Is Essential for the Morphogenesis and Maintenance of Hair Follicles , 2006, Current Biology.

[13]  P. Hawkins,et al.  Signalling through Class I PI3Ks in mammalian cells. , 2006, Biochemical Society transactions.

[14]  R. M. Sharrard,et al.  Regulation of protein kinase B activity by PTEN and SHIP2 in human prostate-derived cell lines. , 2007, Cellular signalling.

[15]  S. Schurmans,et al.  The mouse SHIP2 (Inppl1) gene: complementary DNA, genomic structure, promoter analysis, and gene expression in the embryo and adult mouse. , 1999, Genomics.

[16]  F. Dietrich,et al.  Morphogenesis in skin is governed by discrete sets of differentially expressed microRNAs , 2006, Nature Genetics.

[17]  Y. Kubo,et al.  Lack of somatic mutation in the PTEN gene in squamous cell carcinomas of human skin. , 1999, Journal of dermatological science.

[18]  G. Yancopoulos,et al.  Absence of the lipid phosphatase SHIP2 confers resistance to dietary obesity , 2005, Nature Medicine.

[19]  Yuriy Gusev,et al.  Real-time expression profiling of microRNA precursors in human cancer cell lines , 2005, Nucleic acids research.

[20]  C. Croce,et al.  MicroRNA signatures in human ovarian cancer. , 2007, Cancer research.

[21]  J. M. Thomson,et al.  MicroRNA expression profiles in head and neck cancer cell lines. , 2007, Biochemical and biophysical research communications.

[22]  C. Burge,et al.  Conserved Seed Pairing, Often Flanked by Adenosines, Indicates that Thousands of Human Genes are MicroRNA Targets , 2005, Cell.

[23]  J. Rheinwald,et al.  Tumorigenic keratinocyte lines requiring anchorage and fibroblast support cultured from human squamous cell carcinomas. , 1981, Cancer research.

[24]  T. Tamura,et al.  The SH2-domian-containing inositol 5-phosphatase (SHIP)-2 binds to c-Met directly via tyrosine residue 1356 and involves hepatocyte growth factor (HGF)-induced lamellipodium formation, cell scattering and cell spreading , 2005, Oncogene.

[25]  Ranit Aharonov,et al.  MicroRNA expression detected by oligonucleotide microarrays: system establishment and expression profiling in human tissues. , 2004, Genome research.

[26]  C. Croce,et al.  MicroRNA signatures in human cancers , 2006, Nature Reviews Cancer.

[27]  G Milano,et al.  Influence of epidermal growth factor receptor (EGFR), p53 and intrinsic MAP kinase pathway status of tumour cells on the antiproliferative effect of ZD1839 (‘Iressa’) , 2002, British Journal of Cancer.

[28]  R. Weinberg,et al.  Tumour invasion and metastasis initiated by microRNA-10b in breast cancer , 2007, Nature.

[29]  Phillip A. Sharp,et al.  microRNAs: A Safeguard against Turmoil? , 2007, Cell.

[30]  K. Sylvester,et al.  Repair and regeneration: opportunities for carcinogenesis from tissue stem cells , 2006, Journal of cellular and molecular medicine.

[31]  A. Schermer,et al.  Differentiation-related expression of a major 64K corneal keratin in vivo and in culture suggests limbal location of corneal epithelial stem cells , 1986, The Journal of cell biology.

[32]  S R Datta,et al.  14-3-3 proteins and survival kinases cooperate to inactivate BAD by BH3 domain phosphorylation. , 2000, Molecular cell.

[33]  S. Decker,et al.  SH2-containing 5′-Inositol Phosphatase, SHIP2, Regulates Cytoskeleton Organization and Ligand-dependent Down-regulation of the Epidermal Growth Factor Receptor* , 2005, Journal of Biological Chemistry.

[34]  S. Tseng,et al.  Limbal transplantation for ocular surface reconstruction--a review. , 1991, Fortschritte der Ophthalmologie : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft.

[35]  George A Calin,et al.  Micro-RNA profiling in kidney and bladder cancers. , 2007, Urologic oncology.

[36]  Michael T. McManus,et al.  The microRNA miR-196 acts upstream of Hoxb8 and Shh in limb development , 2005, Nature.

[37]  J. Craft,et al.  Detection of functional PTEN lipid phosphatase protein and enzyme activity in squamous cell carcinomas of the head andeck, despite loss of heterozygosity at this locus , 2001, British Journal of Cancer.

[38]  M. Molls,et al.  Effect of Reoxygenation on the Hypoxia-Induced Up-Regulation of Serine Protease Inhibitor PAI-1 in Head and Neck Cancer Cells , 2007, Oncology.

[39]  P. Vogt,et al.  Phosphatidylinositol 3-kinase signaling mediates angiogenesis and expression of vascular endothelial growth factor in endothelial cells. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[40]  V. Ambros,et al.  The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14 , 1993, Cell.

[41]  T. Sun,et al.  Existence of slow-cycling limbal epithelial basal cells that can be preferentially stimulated to proliferate: Implications on epithelial stem cells , 1989, Cell.

[42]  T. Sun,et al.  Interpreting epithelial cancer biology in the context of stem cells: tumor properties and therapeutic implications. , 2005, Biochimica et biophysica acta.

[43]  Ravi Jain,et al.  MicroRNA-143 Regulates Adipocyte Differentiation* , 2004, Journal of Biological Chemistry.

[44]  A. Klein-Szanto,et al.  Overexpression of cyclin D2 is associated with increased in vivo invasiveness of human squamous carcinoma cells , 2002, Molecular carcinogenesis.

[45]  S. Tseng,et al.  Corneal epithelial stem cells at the limbus: looking at some old problems from a new angle. , 2004, Experimental eye research.

[46]  H. Ishihara,et al.  Dual role of SRC homology domain 2-containing inositol phosphatase 2 in the regulation of platelet-derived growth factor and insulin-like growth factor I signaling in rat vascular smooth muscle cells. , 2003, Endocrinology.

[47]  Q. Chen,et al.  Homozygous deletion of the PTEN tumor-suppressor gene is not a feature in oral squamous cell carcinoma. , 2000, Oral oncology.

[48]  N. Rajewsky,et al.  Silencing of microRNAs in vivo with ‘antagomirs’ , 2005, Nature.

[49]  T. Tuschl,et al.  Identification of Tissue-Specific MicroRNAs from Mouse , 2002, Current Biology.

[50]  K. Gunsalus,et al.  Combinatorial microRNA target predictions , 2005, Nature Genetics.

[51]  J. Testa,et al.  Perturbations of the AKT signaling pathway in human cancer , 2005, Oncogene.

[52]  R. Stephens,et al.  Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. , 2006, Cancer cell.

[53]  M. Stack,et al.  Loss of adhesion‐regulated proteinase production is correlated with invasive activity in oral squamous cell carcinoma , 2002, Cancer.